Dr. Sandra Sanchez-Roige received a DP1 AVENIR Award for her project titled “Building Bridges to Allow Cross-species Translational genetics for the Study of Addiction” by the NIH National Institute on Drug Abuse (NIDA).
NIDA’s Avenir Awards provide grants to early-stage investigators who propose highly innovative studies. Awardees receive up to $300,000 per year for five years to support their projects.
We are now expanding the team to 2 to 3 full time members. If you are interested in the genetics of substance use disorders and developing tools for cross-species genomic integration, please reach out!